Publications 2021

Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S et al. (2021)
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
Lancet Gastroenterol. Hepatol., 6 (11), 933-946
DOI 10.1016/S2468-1253(21)00219-3

Chellappa S, Kushekhar K, Hagness M, Horneland R, Tasken K, Aandahl EM (2021)
The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients
J. Immunol., 207 (10), 2501-2511
DOI 10.4049/jimmunol.2001103

Dueland S, Syversveen T, Hagness M, Grut H, Line PD (2021)
Liver transplantation for advanced liver-only colorectal metastases
Br. J. Surg., 108 (12), 1402-1405
DOI 10.1093/bjs/znab196

Dueland S, Yaqub S, Syversveen T, Carling U, Hagness M, Brudvik KW, Line PD (2021)
Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases
JAMA Surg., 156 (6), 550-557
DOI 10.1001/jamasurg.2021.0267

Hausken J, Haugaa H, Hagness M, Line PD, Melum E, Tonnessen TI (2021)
Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients
Transplant. Direct., 7 (2), e648
DOI 10.1097/TXD.0000000000001101

Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD (2021)
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score
Transpl. Int., 34 (9), 1722-1732
DOI 10.1111/tri.13981

Publications 2020

Dueland S, Grut H, Syversveen T, Hagness M, Line PD (2020)
Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis
Am. J. Transplant., 20 (2), 530-537
DOI 10.1111/ajt.15682

Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bjornbeth BA, Hagness M, Line PD (2020)
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases
Ann. Surg., 271 (2), 212-218
DOI 10.1097/SLA.0000000000003404

Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
BJS Open, 4 (3), 467-477
DOI 10.1002/bjs5.50278

Publications 2019

Dueland S, Line PD, Hagness M, Foss A, Andersen MH (2019)
Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver
BJS Open, 3 (2), 180-185
DOI 10.1002/bjs5.50116

Hagness M, Foss S, Sorensen DW, Syversen T, Bakkan PA, Dahl T, Fiane A, Line P (2019)
Liver Transplant After Normothermic Regional Perfusion From Controlled Donors After Circulatory Death: The Norwegian Experience
Transplant. Proc., 51 (2), 475-478
DOI 10.1016/j.transproceed.2019.01.066

Nordheim E, Storro MO, Natvik AK, Kro GB, Midtvedt K, Reisaeter AV, Hagness M, Fevang B, Pettersen FO (2019)
Donor-derived strongyloidiasis after organ transplantation in Norway
Transpl. Infect. Dis., 21 (1), e13008
DOI 10.1111/tid.13008

Publications 2018

Dueland S, Foss A, Solheim JM, Hagness M, Line PD (2018)
Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma
Br. J. Surg., 105 (6), 736-742
DOI 10.1002/bjs.10769

Line PD, Hagness M, Dueland S (2018)
The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
Can. J. Gastroenterol. Hepatol., 2018, 8547940
DOI 10.1155/2018/8547940

Publications 2017

Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Tasken K, Aandahl EM (2017)
CD8 (+) T Cells That Coexpress ROR gamma t and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
J. Immunol., 198 (4), 1729-1739
DOI 10.4049/jimmunol.1600061

Publications 2016

Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Tasken K, Aandahl EM (2016)
Regulatory T cells that co-express RORt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
OncoImmunology, 5 (4), e1102828
DOI 10.1080/2162402X.2015.1102828

Chellappa S, Lieske NV, Hagness M, Line PD, Tasken K, Aandahl EM (2016)
Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4(+) T cells
J. Leukoc. Biol., 100 (1), 5-16
DOI 10.1189/jlb.2HI0815-334R

Publications 2015

Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, Foss A, Tveit KM (2015)
Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?
Ann. Surg., 261 (5), 956-960
DOI 10.1097/SLA.0000000000000786

Dueland S, Hagness M, Line PD, Guren TK, Tveit KM, Foss A (2015)
Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Ann. Surg. Oncol., 22 (7), 2195-2200
DOI 10.1245/s10434-014-4137-0

Hagness M (2015)
Liver transplantation in treatment of colorectal liver metastases
Hepat. Oncol., 2 (2)
DOI 10.2217/HEP.15.3

Line PD, Hagness M, Berstad AE, Foss A, Dueland S (2015)
A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases The RAPID Concept
Ann. Surg., 262 (1), E5-E9
DOI 10.1097/SLA.0000000000001165

Publications 2014

Hagness M, Foss A, Egge TS, Dueland S (2014)
Patterns of Recurrence After Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer
Ann. Surg. Oncol., 21 (4), 1323-1329
DOI 10.1245/s10434-013-3449-9

Publications 2013

Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S (2013)
Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer
Ann. Surg., 257 (5), 800-806
DOI 10.1097/SLA.0b013e3182823957

Publications 2012

Andersen MH, Dueland S, Hagness M, Vidnes T, Finstad ED, Wahl AK, Foss A (2012)
Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma
Scand. J. Caring Sci., 26 (4), 713-719
DOI 10.1111/j.1471-6712.2012.00984.x

Hagness M, Henjum K, Landskron J, Brudvik KW, Bjornbeth BA, Foss A, Tasken K, Aandahl EM (2012)
Kinetics and Activation Requirements of Contact-Dependent Immune Suppression by Human Regulatory T Cells
J. Immunol., 188 (11), 5459-5466
DOI 10.4049/jimmunol.1101367

Publications 2011

Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dorje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
Single Transplanted Kidneys from A 90-Year-Old Deceased Donor Perform Acceptably at 1 Year
Transplant. Proc., 43 (5), 2107-2109
DOI 10.1016/j.transproceed.2011.01.192